MAC AIDS Project Brief on Innovations to Accelerate Access to Treatment and Care for Children and Adolescents Affected by HIV. The MAC AIDS Fund is designed to address unmet needs for HIV testing, treatment and care among children and adolescents in key BRICS countries (Brazil, the CEE/CIS region, India, and South Africa).
Synthesis Report of the Rapid Assessment of Adolescent and HIV Programme Context in Five Countries: Botswana, Cameroon, Jamaica, Swaziland and Zimbabwe.
The assessment process described in this report was designed to support countries to strengthen the adolescent component of their national HIV programmes. Through the review of existing data on HIV, health and development in adolescents the assessments are a systematic way to identify equity and performance gaps affecting adolescent HIV programming.
PMTCT & Paediatric HIV/TB Lessons & Results from Using New WHO-UNICEF HIV-Adapted Community Materials
"Together We Can Improve"
A case study on joint community-facility review of PMTCT dashboards in Malawi
A robust monitoring and evaluation (M&E) system is a key component of a strong health system. With the current WHO recommendation of lifelong ART for all pregnant and breastfeeding women living with HIV, outcomes (including maternal survival and final infant HIV status) require monitoring through longitudinal data systems complemented with regular cohort analyses and enhanced monitoring. Additionally, as we move toward the need for more strategic policies and programming to garner system and resource efficiencies, M&E systems need to be designed to be able to inform differences arising from age, sex, and geographic trends as well as identify weaknesses such as sub-optimal commodity supply and testing quality.
In 2015, the IATT monitoring and evaluation working group (MEWG) finalized and disseminated the IATT B+ M&E Framework. One mechanism used to disseminate was to convene a 15 Country Consultation that was determined as follows: the eight 2015 priority countries (Cameroon, Kenya, Mozambique, Nigeria, South Africa, Tanzania, Uganda & Zambia) that contributed 70% of new infections among the Global Plan countries in 2013, three countries (Malawi, Rwanda and Zimbabwe) representing best practices from the region and four countries (Botswana, Cote d’Ivoire, DRC and Namibia) who are in the process of reviewing their M&E systems for B+ roll out.
This National Guidelines for Management of HIV and AIDS 5th edition 2015 has taken into consideration the WHO 2013 Consolidated guidelines recommendations of antiretroviral drugs for treating and preventing HIV infection on the use. It provide details on antiretroviral therapy for adults, children, and pregnant and breastfeeding women. In addition, it provides details on the use of ARV drugs (what to do) and operational aspects (how to do it) along the cascade of HIV-care related services.
Our world is also waking up to the reality now that for us to win the fight towards an AIDS free generation, we must fiercely combat TB. What is making the need to double our efforts even more pressing is the growing threat of strains of the disease that do not respond to most antibiotics (multi-drug resistant TB or MDR-TB). The overlap of TB and HIV is a deadly combination with tragic consequences. TB is the leading killer of people with HIV, accounting for one in four HIV-related deaths. Globally, one-third of people living with HIV are also infected with TB, and if left unchecked and untreated, TB can kill a person with HIV/AIDS in a matter of weeks.
This third edition of the Malawi Guidelines for Clinical Management of HIV in Children and Adults will be implemented starting May 2016. It replaces all previous editions of the Malawi Antiretroviral therapy (ART) and Prevention of Mother to Child Transmission (PMTCT) guidelines. This document is written for medical doctors, clinical officers, medical assistants, nurses, midwives, health surveillance assistants (HSAs) and medical records clerks who are working in public and private sector health facilities in Malawi. It is designed to be a practical guide for implementation of integrated HIV Services.
This 2016 version of the Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection provides simplified guidance on a continued approach that positively affects the continuum of HIV care, while adding to innovative methods that will reduce transmission rates and increase life span for those on treatment. This is all to further accelerate efforts to meet the ambitious Fast-Track target for 2020, including achieving major reductions in the number of people dying from HIV-related causes and the 90–90–90 treatment target.